The Stanford - Resolve Biosciences Spatially Resolved Transcriptomics Early Access Opportunity
Apply for one of three Molecular CartographyTM RNA Profiling projects before 08/30/2021
What is the Spatially Resolved Transcriptomics Early Access Opportunity?
Nature declared spatially resolved transcriptomics 2020 Method of the year. Without a doubt this emerging field is going to play a major role in transforming our understanding of systems biology. This powerful method will impact your research by providing answers to scientific questions previously left unanswered. Therefore, Resolve Biosciences with Stanford University Protein and Nucleic Acid (PAN) Facility, will demonstrate this valuable technology by providing instrument access to three Molecular Cartography RNA profiling projects, of 8 samples each, to scientists who propose projects that can advance their field of study. Projects will be selected based on technical feasibility and the potential to accelerate a specific area of research.
What is Molecular CartographyTM?
This pioneering platform produces deep contextual data sets that illuminate molecular interactions at subcellular resolution while maintaining tissue integrity. Molecular Cartography interrogates RNA transcript activity from 100 genes of your choice per sample run, with each slide suitable for up to 8 samples. Click here to download information demonstrating the utility of spatial genomics.
Application
Notification of award 09/07/2021
Which species and tissue types can be used?
- Non-tumor: human or mouse brain, liver, heart, kidney (fresh frozen with a RIN score >6)
- Tumor: human, PDX, or mouse NSCLC, breast, CRC PrC (fresh frozen with a RIN score of >6)*
*Note: method development for some tumor samples will be required
*We cannot guarantee FFPE samples at this time
What are the terms and conditions of the project?
- Publications and Promotion: You will be asked to verify on the application landing page that you are willing to co-present your data on 2 occasions within 3 months of project completion (excepting data reserved for original content in a peer-reviewed journal)
- Samples: You will be asked to confirm that samples will be available for processing within 15 business days of project award.
- Informed consent: All human samples must have received IRB approval and informed consent to be used for research purposes.
- Communication: You will be asked to verify that you will respond to Resolve Biosciences communications, during the project award and project completion, within 3 business days.
- If any of the above requirements cannot be met, unless agreed to by both parties, the project award may be forfeited.
What if I have questions?
For technical questions, please contact Sam Stingley, PhD: [email protected]
For general questions contact the Core Director, Michael Eckart, PhD: [email protected]
